Experience of totally implantable venous access devices (TIV ADs) in adults with cystic fibrosis over a 13-year period

Respiratory Medicine

Volumn 94, Issue 12, 2000, Pages 1161-1165

  Kariyawasam, H H ^a   Pepper, J R ^a   Hodson, M E ^a   Geddes, D M ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cystic fibrosis; Venous access

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DEVICE; DISEASE DURATION; EXPERIENCE; HOSPITAL; HUMAN; IMPLANTATION; INCIDENCE; INFECTION; LONG TERM CARE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBCLAVIAN VEIN; VASCULAR ACCESS; VEIN THROMBOSIS;

EID: 0034521333     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2000.0943     Document Type: Article

References (11)

1. Totally implantable vascular access in treatment of cystic fibrosis
2. Totally implantable system for venous access in children with cystic fibrosis
3. Totally implantable venous access devices in children with cystic fibrosis: Incidence and type of complications
4. A typical thrombotic and septic complications of totally implantable venous access devices in patients with cystic fibrosis
5. Totally implantable vascular access devices in cystic fibrosis: A four year experience with fifty-eight patients
6. Totally implantable venous access devices in adult patients with cystic fibrosis
7. Use of a totally implantable system for venous access in cystic fibrosis
8. Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis
9. Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis
10. Candidaemia: Risk factors in patients with cystic fibrosis who have totally implantable venous access systems
11. Management of pneumothorax in adults with cystic fibrosis